IP31-15: A Phase 1 Safety, PK and Preliminary Efficacy Study of Localized Therapy using Enolen® (Enzalutamide) Implants for Early-Stage Prostate Cancer
Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
145AB
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!